Joint venture China, subsidiary (WFOE) or hybrid?
By Frank-Christan Raffel Frank-Christian Raffel has been analyzing and shaping the strategy and corporate form of European companies in China and Southeast Asia since 1997, when he conducted a broad-based study in cooperation with the Hong Kong and Shanghai Chambers of Commerce. It is remarkable how often we hear the question even today, in the […]
EMTS concludes strategic asset deal: Pioneer for biomedical services in the Philippines
Manila, Philippines EMTS Inc. and PHD Inc. have successfully concluded an agreement, effective January 1, 2025, transferring PHD’s entire medical device maintenance and calibration business in the Philippines to EMTS Inc. This strategic partnership ensures that over 140 hospitals, clinics and laboratories across the Philippines continue to receive world-class service, now enhanced by EMTS Inc.’s […]
Dr. Franz Köhler Chemie: Establishment of its own subsidiary in China with an innovative shareholder model
By Frank-Christian Raffel Dr. Franz Köhler Chemie (DFKC) is a research-intensive and innovative pharmaceutical company and is owner-managed in the third generation. DFKC is, among other things, the manufacturer of the organ-protective solution CUSTODIOL©, which is distributed worldwide by DFKC. Starting Point China is one of the most important markets in the world for DFKC. […]